Am J Surg Pathol

1. RUTLAND CD, Kingsley LG, Zdravkovic S, Vohra P, et al
   Immunohistochemical and Molecular Features Distinguishing Metaplastic Breast Carcinoma With Squamous Differentiation From Cutaneous Squamous Cell Carcinoma.
   Am J Surg Pathol. 2026;50:1372-1387.
   

   >> Share

   
   
2. COLON CARTAGENA L, Perera N, Liang Y, Zhan H, et al
   Lessons Learned From 26 Adenomyoepitheliomas of the Breast.
   Am J Surg Pathol. 2026;50:1281-1293.
   

   >> Share

   
   

   
   Ann Oncol

3. JIAO D, Sun X, Qiao J, Jia H, et al
   Efficacy and safety of camrelizumab plus docetaxel and carboplatin as neoadjuvant therapy for stage II-III triple-negative breast cancer: the HELEN-Trio 011 randomized clinical trial.
   Ann Oncol. 2026 Oct 16:S0923-7534(26)06884-5. doi: 10.1016/j.annonc.2026.
   

   >> Share

   
   

   
   Ann Surg

4. ALLEN LR, Plitas G, Sawka R, Barrio AV, et al
   De-escalation of Axillary Surgery in Early Breast Cancer: Translating SOUND and INSEMA into Clinical Practice.
   Ann Surg. 2026 Oct 12. doi: 10.1097/SLA.0000000000007232.
   

   >> Share

   
   

   
   Ann Surg Oncol

5. NELIS M, Zhang L, Gadi VK, Chichura AM, et al
   Neoadjuvant Chemo-Immunotherapy Yields Survival Comparable to Upfront Surgery in Metaplastic Breast Cancer: A National Cancer Database Analysis.
   Ann Surg Oncol. 2026 Oct 16. doi: 10.1245/s10434-026-20713.
   

   >> Share

   
   
6. TEITELBAUM A, Yono SS, Cheung WL, Springer K, et al
   ASO Visual Abstract: Baseline Differences in Patient-Reported Quality of Life Across Breast Cancer Surgical Pathways.
   Ann Surg Oncol. 2026 Oct 13. doi: 10.1245/s10434-026-20743.
   

   >> Share

   
   
7. LUKAC S, Schaffler H, Leinert E, Reimer T, et al
   ASO Visual Abstract: Real World Clinical, Enviro-logistical, and Economic Implications of Sentinel Lymph Node Biopsy Omission in Early Breast Cancer.
   Ann Surg Oncol. 2026 Oct 11. doi: 10.1245/s10434-026-20660.
   

   >> Share

   
   

   
   BMC Cancer

8. REISIG E, Cai L, Muller M, Schafgen B, et al
   Machine learning model for the prediction of pathological complete response after neoadjuvant chemotherapy in breast cancer.
   BMC Cancer. 2026;26:1229.
   

   >> Share

   
   

   
   BMJ

9. FURNEAUX R
   NICE rejects breast cancer drug over cost.
   BMJ. 2026;395:e101150.
   

   >> Share

   
   

   
   Breast Cancer

10. SALAM K, Numan H, Zreik AE, Skaini MB, et al
    Limited clinical value of routine PET/CT in early-stage breast cancer: a multicenter retrospective study.
    Breast Cancer. 2026 Oct 13. doi: 10.1007/s12282-026-01927.
    

    >> Share

    
    
11. SUZUKI H, Tsukuda M, Ueda N, Yodogawa T, et al
    Time toxicity in breast cancer care: a nationwide cross-sectional survey of multidimensional time burden in Japan.
    Breast Cancer. 2026 Oct 15. doi: 10.1007/s12282-026-01926.
    

    >> Share

    
    

    
    Breast Cancer Res

12. BRAHIMETAJ R, Cornelis J, Courtoy G, Waelput W, et al
    Micro-CT radiomics reveals the microcalcification-surrounding tissue interface as the diagnostic epicenter of breast microcalcifications.
    Breast Cancer Res. 2026;28:173.
    

    >> Share

    
    
13. ANNIS DA, Thompson KN, Ju JA, Mull M, et al
    Melanoma cell adhesion molecule (MCAM) mediates microtentacle generation, homotypic clustering, and reattachment of non-adherent breast tumor cells.
    Breast Cancer Res. 2026;28:174.
    

    >> Share

    
    

    
    Breast J

14. ZHANG Y, Han A, Yang S, Zhao J, et al
    Dosimetric Comparison of Five Radiotherapy Techniques in Left-Sided Breast Cancer Patients Following Breast-Conserving Surgery.
    Breast J. 2026;2026:e6666976.
    

    >> Share

    
    
15. LIU S, Song Q
    The Effect of Clinicopathological Features and Postoperative Management on Prognosis in Male Breast Cancer.
    Breast J. 2026;2026:e2806453.
    

    >> Share

    
    

    
    Cancer

16. ZHANG BX, Sella T, Zheng Y, Kirkner GJ, et al
    Delays in breast cancer presentation, diagnosis, and treatment in young women.
    Cancer. 2026;132:e70594.
    

    >> Share

    
    

    
    Cancer Chemother Pharmacol

17. PAN J, Zhang W, Yang X
    Research and development of a multi-target HER2 inhibitor (CPD 1) and its mechanism and application in combating HER2-positive breast cancer.
    Cancer Chemother Pharmacol. 2026;96:119.
    

    >> Share

    
    

    
    Cancer Lett

18. DENG W, Fan Y, Zhang H, Wu S, et al
    MDK(+) cancer-associated fibroblasts promote immunotherapy resistance through mitochondrial reprogramming in breast cancer.
    Cancer Lett. 2026 Oct 14:218884. doi: 10.1016/j.canlet.2026.218884.
    

    >> Share

    
    

    
    Clin Breast Cancer

19. LENAERTS M, Kooreman LFS, van Amstel FJG, van Diest PJ, et al
    Value of Breast and Axillary Tumor-Infiltrating Lymphocytes for Response to Neoadjuvant Chemo-(Immuno)Therapy in Clinically Node-Positive Breast Cancer.
    Clin Breast Cancer. 2026;26:17-24.
    

    >> Share

    
    
20. ERDOGAN S, Yilmaz Y, Aslan ER, Yukselturk R, et al
    Prognostic Value of Baseline Metabolic Tumor Volume on [(18)F]FDG PET/CT in Metastatic Breast Cancer Treated With CDK4/6 Inhibitors.
    Clin Breast Cancer. 2026;26:25-31.
    

    >> Share

    
    

    
    Clin Cancer Res

21. SLEDGE GW, Xiu J, Fuqua S, Ribeiro JR, et al
    Differential impact of tumor-derived ESR1 mutations on elacestrant benefit in metastatic breast cancer.
    Clin Cancer Res. 2026 Oct 13. doi: 10.1158/1078-0432.CCR-26-2215.
    

    >> Share

    
    
22. FITZPATRICK A, Shanmugalingam T, Haider S, Maruzani R, et al
    Cerebrospinal fluid and plasma circulating tumor DNA dynamics as a biomarker of response during trastuzumab deruxtecan treatment in patients with breast cancer with leptomeningeal disease.
    Clin Cancer Res. 2026 Oct 13. doi: 10.1158/1078-0432.CCR-26-1885.
    

    >> Share

    
    
23. PLADSEN AV, Smebye ML, Garred O, Borgen E, et al
    DNA-Based Biomarkers as Predictors of Carboplatin Response in Neoadjuvant Treatment for Hormone Receptor Positive and Triple-Negative Breast Cancer.
    Clin Cancer Res. 2026 Oct 14. doi: 10.1158/1078-0432.CCR-26-2212.
    

    >> Share

    
    

    
    Eur Radiol

24. PETERS J, van der Waal D, van Gils CH, Broeders MJM, et al
    Comparison of three algorithms to measure breast density on mammograms in a population-based screening cohort.
    Eur Radiol. 2026;36:8347-8358.
    

    >> Share

    
    
25. KIM HJ, Choi WJ, Yoon GY, Eom HJ, et al
    Preoperative breast MRI and long-term survival in ductal carcinoma in situ: a propensity score-weighted analysis.
    Eur Radiol. 2026;36:8394-8406.
    

    >> Share

    
    

    
    Int J Radiat Oncol Biol Phys

26. ZEREY MM, Gal O, Feenstra NA, Fagundes M, et al
    Does Pencil Beam Scanning Proton Therapy Impart a Higher Risk of Capsular Contracture Compared With Intensity Modulated Photon Radiation Therapy in the Postmastectomy Reconstruction Setting?
    Int J Radiat Oncol Biol Phys. 2026;126:1211-1219.
    

    >> Share

    
    
27. GERGELIS KR, Afzal A, Mullikin TC, Harmsen WS, et al
    Comparative Analysis of Acute Skin Reactions After Postmastectomy Photon and Intensity Modulated Proton Therapy.
    Int J Radiat Oncol Biol Phys. 2026;126:1185-1195.
    

    >> Share

    
    
28. CHEN J, Ma Z, Cao M, Gao RW, et al
    Dose-Linear Energy Transfer Interactions Predict Capsular Contracture After Proton Postmastectomy Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2026;126:1196-1210.
    

    >> Share

    
    
29. RAHMAN MM, Berg TJ, Allawi RH, Zaborek J, et al
    Effects of prior irradiation on the microenvironment of a radiation-associated breast cancer model increase sensitivity to immune checkpoint inhibition.
    Int J Radiat Oncol Biol Phys. 2026 Oct 14:S0360-3016(26)04335.
    

    >> Share

    
    

    
    J Clin Invest

30. BAYLEY R, Qu X, Chakraborty A, Shamma M, et al
    Combined inhibition of DNA Polymerase Theta and ATR targets MYBL2-high triple-negative breast cancer stem cells.
    J Clin Invest. 2026 Oct 13:e202898. doi: 10.1172/JCI202898.
    

    >> Share

    
    
31. YOUNG KS, Fanning SW
    Selective estrogen receptor degraders and their effect on the breast cancer immune microenvironment.
    J Clin Invest. 2026;136:e207633.
    

    >> Share

    
    
32. NAPOLITANO F, Unni N, Arteaga CL
    PI3K signaling in breast cancer: therapeutic advances versus adaptive resistance.
    J Clin Invest. 2026;136:e207635.
    

    >> Share

    
    
33. XIAO Y, Yang F, Qi YJ, Chen L, et al
    Multimodal assessment of exceptional responders refines subtyping-directed precision treatment in HR+/HER2- breast cancer.
    J Clin Invest. 2026;136:e202305.
    

    >> Share

    
    
34. SERIAK D, Kim JY, Shapiro GI, Giordano A, et al
    Next-generation CDK inhibitors in HR+/HER2- breast cancer.
    J Clin Invest. 2026;136:e207631.
    

    >> Share

    
    

    
    J Natl Cancer Inst

35. ZHANG X, Shi J
    RE: Early discontinuation of chemotherapy in older adults with early breast cancer: results from the prospective multicenter HOPE study.
    J Natl Cancer Inst. 2026 Oct 12:djag378. doi: 10.1093.
    

    >> Share

    
    
36. BODELON C, McCullough LE, York C, Shams-White MM, et al
    Alignment with lifestyle recommendations and physical health in breast cancer survivors and women without cancer.
    J Natl Cancer Inst. 2026 Oct 13:djag388. doi: 10.1093.
    

    >> Share

    
    
37. AHMED S, Seror R, Mariette X, Maclin BJ, et al
    Associations between breast cancer and rheumatoid arthritis among older-age women in the United States.
    J Natl Cancer Inst. 2026 Oct 13:djag387. doi: 10.1093.
    

    >> Share

    
    
38. ZHAO C, Kawaguchi ES, Maskarinec G, Conti DV, et al
    Lifestyle and genetic risk factors for postmenopausal breast cancer in the multiethnic cohort.
    J Natl Cancer Inst. 2026 Oct 15:djag394. doi: 10.1093.
    

    >> Share

    
    

    
    J Nucl Med

39. XIA L, Gong Y, He C, Mei B, et al
    B7H3-Targeted Molecular Imaging for Highly Specific Diagnosis and In Vivo Noninvasive Detection of B7H3 in Breast Cancer.
    J Nucl Med. 2026 Oct 15:jnumed.126.272939. doi: 10.2967/jnumed.126.272939.
    

    >> Share

    
    

    
    J Surg Oncol

40. MATHEWS AL, Piltin MA, Wing SE, Hamm NC, et al
    Repeat Breast Cancer Surgeries After Segmental Mastectomy Meaningfully Increase Long Term Healthcare Costs.
    J Surg Oncol. 2026 Oct 12. doi: 10.1002/jso.70419.
    

    >> Share

    
    

    
    Oncogene

41. LIU X, Zhang K, Zhang Y, Wang Y, et al
    PTK7 scaffolds DNA-PKcs to promote DNA damage response and immune evasion in triple-negative breast cancer.
    Oncogene. 2026 Oct 10. doi: 10.1038/s41388-026-04011.
    

    >> Share

    
    

    
    PLoS Comput Biol

42. RIUDAVETS PUIG R, O'Mahony DG, Brorson IS, Sokolova K, et al
    HiFIseek: Gene-specific enrichment of high-impact mutations in associated genomic regions.
    PLoS Comput Biol. 2026;22:e1014842.
    

    >> Share

    
    

    
    PLoS One

43. ZEMNI I, Maatouk A, Boufrikha W, Bennasrallah C, et al
    Survival and disease burden of breast cancer (Monastir, Tunisia): A population-based cohort study (2002-2022).
    PLoS One. 2026;21:e0360398.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

44. PARRISH M, Seraj M, Nikoueian H, Traugh N, et al
    Environmental chemical mixtures reprogram mammary epithelial development to epigenetic states associated with breast cancer.
    Proc Natl Acad Sci U S A. 2026;123:e2613054123.
    

    >> Share

    
    

    
    Radiol Cardiothorac Imaging

45. PANQUEVA GIRALDO LN, Del Castillo Herazo V, Pinzon Valderrama B
    Coronary Calcium after Breast Cancer Radiotherapy: Balancing Risk Stratification and Feasibility in Resource-limited Settings.
    Radiol Cardiothorac Imaging. 2026;8:e260304.
    

    >> Share

    
    

    
    Radiology

46. VAN GRINSVEN SEL, Monninkhof EM, Mann RM, Lobbes MBI, et al
    Supplemental Breast Cancer Screening with Contrast-enhanced Mammography or Abbreviated MRI for Extremely Dense Breasts: The DENSE-2 Trial.
    Radiology. 2026;321:e260333.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share